Gene Panel Market by Product & Services (Test Kits and Testing Services), by Techniques (Amplicon-based Approach and Hybridization-based Approach), by Design (Predesigned Gene Panels and Customized Gene Panels), by Application (Cancer Risk Assessment, Syndrome-specific, High-penetrance, High and Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis of Congenital Diseases, Pharmacogenetics, and Others), and by End-user Industry (Research and Academic Institutes, Hospital and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 – 2029

                                          
Abstract
                    
The report covers forecast and analysis for the gene panel market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the gene panel market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the gene panel market on a global level.

In order to give the users of this report a comprehensive view of the gene panel market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study includes a market attractiveness analysis, where all segments are benchmarked supported their market size, rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the gene panel market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on product and services, the global gene panel market is segmented into test kits and test kits services. Based on technology the market is segmented into two types amplicon and hybridization. Based on design, the market is segmented into predesigned and customized. Based on application, the market is segmented into cancer risk assessment, diagnosis of congenital diseases, and others. Based on end-users, the global gene panel market is segmented into five types: pharmaceutical companies, hospitals & clinics, educational institutes, food & beverage industry, and others.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for gene panel based on individual segment and applications in all the regions and countries.

The report covers detailed competitive outlook including the market share, reimbursement policy and company profiles of the key participants operating in the global Gene Panel market include Illumina, Inc., BGI, Agilent Technologies, Eurofins Scientific, QIAGEN, GENEWIZ, Inc., Novogene Corporation, Personalis, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and others

This report segments the global gene panel market as follows:

Global Gene Panel Market: Product & Service Type Analysis

	Test Kits and 
	Testing Services

Global Gene Panel Market: Techniques Type Analysis

	Amplicon-based Approach,
	Hybridization-based Approach

Global Gene Panel Market: Design Type Analysis

	Predesigned Gene Panels
	Customized Gene Panels

Global Gene Panel Market: Application Type Analysis

	Cancer Risk Assessment
	Diagnosis of Congenital Diseases
	Pharmacogenetics
	Others

Global Gene Panel Market: End-Users Analysis

	Research and Academic Institutes
	Hospital and Diagnostic Laboratories
	Pharmaceutical and Biotechnology Companies
	Others 

Global Gene Panel Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	The Middle East and Africa